It is a pharma private limited company based in New Delhi, Delhi, India, established in 2020.
2020 | New Delhi, Delhi, India | ActiveJasmyrah Pharmaceutical Private Limited, a active private limited company, was established on 23 December 2020 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909DL2020PTC374905. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Piyush Porwal (Additional Director), Satender Pal Singh (Additional Director), Himanshu Vaid (Director). Past directors included Dhani Jindal, Yash Porwal. Its latest AGM occurred on 31 December 2021, with the balance sheet filed on 31 March 2021. It is based at 21/20A Ground Floor, Tilak Nagar, New Delhi, Delhi, 110018.
U51909DL2020PTC374905
374905
23 December 2020
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Jasmyrah Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Piyush Porwal | Additional Director | 07 Jul 2023 | Current |
| Satender Pal Singh | Additional Director | 20 Dec 2021 | Current |
| Himanshu Vaid | Director | 03 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Sep 2021 | Past |
| Pramod Abcsdd | Director | 10 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jasmyrah Pharmaceutical Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Jasmyrah Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Jasmyrah Pharmaceutical has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jasmyrah Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jasmyrah Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Piyush Porwal was appointed as a Additional Director was appointed as a Additional Director on 07 Jul 2023 & has been associated with this company since 2 years 4 months . was completed.
Progress on Jasmyrah Pharmaceutical Private Limited last Annual general meeting of members was held on 31 Dec 2021 as per latest MCA records. was documented.
Satender Pal Singh was appointed as a Additional Director was appointed as a Additional Director on 20 Dec 2021 & has been associated with this company since 3 years 11 months . was recorded as a recent event.
Progress on Himanshu Vaid was appointed as a Director was appointed as a Director on 03 Sep 2021 & has been associated with this company since 4 years 2 months . was documented.
Jasmyrah Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was recorded as a recent event.
Jasmyrah Pharmaceutical Private Limited was registered on 23 Dec 2020 with Roc Delhi & aged 4 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Jasmyrah Pharmaceutical Private Limited is U51909DL2020PTC374905.
Jasmyrah Pharmaceutical Private Limited is headquartered at 21/20A Ground Floor, Tilak Nagar, New Delhi, Delhi, 110018.
Jasmyrah Pharmaceutical Private Limited was incorporated on 23 December 2020.
The current directors of Jasmyrah Pharmaceutical Private Limited are
The primary industry of Jasmyrah Pharmaceutical Private Limited is Pharma.
Jasmyrah Pharmaceutical Private Limited is unlisted.
The authorized capital of Jasmyrah Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Jasmyrah Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX